Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Terry-Ann Burrell net worth and biography

Terry-Ann Burrell Biography and Net Worth

CFO of Beam Therapeutics

Terry-Ann Burrell has served as our Chief Financial Officer since August 2019 and as our Chief Financial Officer and Treasurer since September 2019. From May 2008 to August 2019, Ms. Burrell worked at J.P. Morgan Securities LLC, where she most recently served as Managing Director. Ms. Burrell was responsible for deal execution across both mergers and acquisitions and capital markets. In her role, she advised biotechnology and pharmaceutical companies on strategic considerations, including mergers and acquisitions, initial public and secondary offerings and valuation analysis. Ms. Burrell currently serves on the board of directors of Recursion Pharma, a biotherapeutics company. Ms. Burrell holds a bachelor’s degree from Harvard College and an MBA from New York University’s Leonard N. Stern School of Business. Provided by Tagnifi.

What is Terry-Ann Burrell's net worth?: The estimated net worth of Terry-Ann Burrell is at least $1.68 million as of April 1st, 2024. Ms. Burrell owns 70,137 shares of Beam Therapeutics stock worth more than $1,676,274 as of April 20th. This net worth estimate does not reflect any other investments that Ms. Burrell may own. Additionally, Ms. Burrell receives a salary of $711,150.00 as CFO at Beam Therapeutics. Learn More about Terry-Ann Burrell's net worth.
How old is Terry-Ann Burrell?: Ms. Burrell is currently 47 years old. There are 2 older executives and no younger executives at Beam Therapeutics. The oldest executive at Beam Therapeutics is Dr. Giuseppe Ciaramella Ph.D., President, who is 55 years old. Learn More on Terry-Ann Burrell's age.
What is Terry-Ann Burrell's salary?: As the CFO of Beam Therapeutics Inc., Ms. Burrell earns $711,150.00 per year. There are 2 executives that earn more than Ms. Burrell. The highest earning executive at Beam Therapeutics is Mr. John M. Evans M.B.A., CEO & Director, who commands a salary of $1,110,000.00 per year. Learn More on Terry-Ann Burrell's salary.
How do I contact Terry-Ann Burrell?: The corporate mailing address for Ms. Burrell and other Beam Therapeutics executives is 26 LANDSDOWNE STREET, CAMBRIDGE MA, 02139. Beam Therapeutics can also be reached via phone at 857-327-8775 and via email at [email protected]. Learn More on Terry-Ann Burrell's contact information.
Has Terry-Ann Burrell been buying or selling shares of Beam Therapeutics?: Within the last three months, Terry-Ann Burrell has sold $174,925.52 of Beam Therapeutics stock. Most recently, Terry-Ann Burrell sold 5,446 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $32.12, for a transaction totalling $174,925.52. Following the completion of the sale, the chief financial officer now directly owns 70,137 shares of the company's stock, valued at $2,252,800.44. Learn More on Terry-Ann Burrell's trading history.
Who are Beam Therapeutics' active insiders?: Beam Therapeutics' insider roster includes Terry-Ann Burrell (CFO), Giuseppe Ciaramella (Insider), Graham Cooper (Director), John Evans (CEO), and John Evans (CEO). Learn More on Beam Therapeutics' active insiders.
Are insiders buying or selling shares of Beam Therapeutics?: In the last twelve months, insiders at the sold shares 13 times. They sold a total of 319,468 shares worth more than $9,885,604.19. The most recent insider tranaction occured on April, 1st when insider Amy Simon sold 7,157 shares worth more than $229,954.41. Insiders at Beam Therapeutics own 4.4% of the company. Learn More about insider trades at Beam Therapeutics.
Information on this page was last updated on 4/1/2024.

Terry-Ann Burrell Insider Trading History at Beam Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Sell	5,446	$32.12	$174,925.52	70,137
4/3/2023	Sell	2,454	$30.31	$74,380.74	49,303
1/26/2023	Sell	1,102	$45.16	$49,766.32	31,277
1/24/2023	Sell	14,810	$45.01	$666,598.10	31,277
1/18/2023	Sell	47,195	$45.14	$2,130,382.30	31,277
3/31/2022	Sell	1,787	$59.11	$105,629.57	38,278
6/30/2021	Sell	30,000	$122.00	$3,660,000.00
6/28/2021	Sell	45,000	$107.69	$4,846,050.00	69,809

Terry-Ann Burrell Buying and Selling Activity at Beam Therapeutics

Beam Therapeutics Company Overview

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; BEAM-201, an anti-CD7 CAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $23.90

$23.65

$24.94

50 Day Range

MA: $33.09

$24.31

$45.07

2 Week Range

Now: $23.90

$16.95

$49.50

Volume

4,536,873 shs

Average Volume

1,441,603 shs

Market Capitalization

$1.95 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Terry-Ann Burrell Biography and Net Worth

What is Terry-Ann Burrell's net worth?

How old is Terry-Ann Burrell?

What is Terry-Ann Burrell's salary?

How do I contact Terry-Ann Burrell?

Has Terry-Ann Burrell been buying or selling shares of Beam Therapeutics?

Who are Beam Therapeutics' active insiders?

Are insiders buying or selling shares of Beam Therapeutics?